NCT04763044 - Evaluation of the Fluoride Dose Response Using In Situ Caries Model | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

July 21, 2021

Study Completion Date

July 21, 2021

Conditions

Caries

Interventions

DRUG

0 ppm F

Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study.

DRUG

250 ppm F as MFP

Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study.

DRUG

1100 ppm as MFP

Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study.

DRUG

2800 ppm F as MFP

Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study.

DRUG

1100 ppm SnF2

Each subject will be assigned to this treatment during the fifth period for this crossover study.

Trial Locations (1)

Oral Health Research Institute, Indianapolis

All Listed Sponsors

lead

Procter and Gamble

INDUSTRY